Literature DB >> 7916274

Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests.

B D Beleslin1, M Ostojic, J Stepanovic, A Djordjevic-Dikic, S Stojkovic, M Nedeljkovic, G Stankovic, Z Petrasinovic, L Gojkovic, Z Vasiljevic-Pokrajcic.   

Abstract

BACKGROUND: Exercise and pharmacological stress echocardiography have emerged as convenient alternatives to myocardial scintigraphy. The objective of this study was to compare in the same patients the diagnostic values of exercise, dobutamine, and dipyridamole stress echocardiography tests for detection of myocardial ischemia. METHODS AND
RESULTS: We performed exercise (maximal treadmill Bruce protocol), dobutamine (up to 40 micrograms/kg per minute) and dipyridamole (up to 0.84 mg/kg over 10 minutes) stress echocardiography tests, in random sequence and on separate days, in 136 consecutive patients. All patients underwent coronary angiography. Significant coronary artery disease was defined by quantitative coronary angiography as a lesion with a diameter stenosis > or = 50%. A stress echocardiogram was considered positive when new or worsening of preexisting wall motion abnormality was observed. Most of the patients (94%) were receiving the same antianginal medication for each stress test; 59 patients were receiving concomitant beta-blocker therapy. The prevalence of coronary artery disease was 87.5%, with 108 patients having one-vessel coronary artery disease. Peak heart rate and systolic blood pressure were higher with exercise than with dobutamine or dipyridamole (P < .01). Sensitivity of exercise, dobutamine, and dipyridamole stress echocardiography was 88%, 82%, and 74% (dipyridamole versus exercise, P < .01), respectively. Specificity was 82%, 77%, and 94%, respectively. The overall accuracy was 87%, 82%, and 77% (dipyridamole versus exercise, P < .01), respectively. The accuracy of dipyridamole was higher (P = .02) in the group of patients not receiving beta-blockers (84%) than in the patients receiving beta-blocker therapy (66%), whereas the accuracy of exercise and dobutamine were only slightly higher in the patients not receiving beta-blockers. Significant side effects occurred in 3%, 11%, and 1% of patients during exercise, dobutamine, and dipyridamole tests, respectively.
CONCLUSIONS: Despite the different hemodynamic effects, exercise, dobutamine, and dipyridamole echocardiography have high overall diagnostic values. In this group of patients with a predominance of one-vessel coronary artery disease, the overall diagnostic accuracy of stress echocardiography tests was higher for exercise than for dobutamine or dipyridamole. Concomitant beta-blocker therapy significantly decreased the accuracy of the dipyridamole stress echocardiography test. Pharmacological stress testing (dipyridamole without beta-blockers) can therefore be used as an efficient option for detection of myocardial ischemia in patients who are unable or poorly motivated to exercise adequately.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916274     DOI: 10.1161/01.cir.90.3.1168

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Anatomy of a meta-analysis: a critical review of "exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance".

Authors:  S M Kymes; D E Bruns; L J Shaw; K N Gillespie; J W Fletcher
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Contrast agents provide a faster learning curve in dipyridamole stress echocardiography.

Authors:  Jose Zamorano; Violeta Sánchez; Raúl Moreno; Carlos Almería; Jose Rodrigo; Viviana Serra; Luis Azcona; Adalia Aubele; Luis Mataix; Luis Sánchez-Harguindey
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

3.  Exercise echocardiography.

Authors:  Jesus Peteiro; Alberto Bouzas-Mosquera
Journal:  World J Cardiol       Date:  2010-08-26

4.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

5.  Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individuals: feasibility, normal values and reproducibility.

Authors:  Björn Goebel; Raoul Arnold; Eric Koletzki; Herbert E Ulmer; Joachim Eichhorn; Martin Borggrefe; Hans R Figulla; Tudor C Poerner
Journal:  Int J Cardiovasc Imaging       Date:  2006-07-26       Impact factor: 2.357

Review 6.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 7.  Contrast echocardiography for detection of myocardial perfusion abnormalities : A clinical perspective.

Authors:  N Karogiannis; R Senior
Journal:  Herz       Date:  2017-05       Impact factor: 1.443

8.  Detection of prolonged regional myocardial systolic dysfunction after exercise-induced myocardial ischemia by strain echocardiography with high frame rate tissue Doppler echocardiography.

Authors:  Yasuhiro Takagi; Takeshi Hozumi; Yasuhiko Takemoto; Kazuaki Negishi; Zhu Hong; Kohji Abo; Kazuya Fujioka; Mitsuru Nakao; Ryo Otsuka; Kenichi Sugioka; Yoshiki Kobayashi; Hiroyuki Yamagishi; Minoru Yoshiyama; Junichi Yoshikawa
Journal:  J Echocardiogr       Date:  2011-02-11

9.  Dipyridamole stress echocardiography stratifies outcomes of asymptomatic patients with recent myocardial revascularization.

Authors:  Andrea Rossi; Tiziano Moccetti; Francesco Faletra; Paolo Cattaneo; Mariagrazia Rossi; Elena Pasotti; Cecilia Fantoni; Claudio Anzà; Massimo Baravelli
Journal:  Int J Cardiovasc Imaging       Date:  2007-12-22       Impact factor: 2.357

10.  Feasibility of real-time three-dimensional stress echocardiography: pharmacological and semi-supine exercise.

Authors:  Lorenza Pratali; Sabrina Molinaro; Anca I Corciu; Emilio M Pasanisi; Marco Scalese; Rosa Sicari
Journal:  Cardiovasc Ultrasound       Date:  2010-03-24       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.